{"id":16894,"type":"page","link":"https:\/\/www.ortaakarsu.net\/?page_id=16894","title":{"rendered":"Glycopyrrolate + Orphenadrine"},"content":{"rendered":"<p>Source-based drug interaction information. Detailed information is available with page access.<\/p>","protected":true},"excerpt":{"rendered":"<p>Source-based drug interaction information. Detailed information is available with page access.<\/p>","protected":true},"ism_preview":{"drugs":[{"title":"Glycopyrrolate","url":"https:\/\/www.ortaakarsu.net\/?page_id=11767","facts":[{"label":"Active ingredient \/ generic name","value":"glycopyrrolate (glycopyrronium bromide)"},{"label":"ATC code","value":"A03AB02"}]},{"title":"Orphenadrine","url":"https:\/\/www.ortaakarsu.net\/?page_id=11750","facts":[{"label":"Active ingredient \/ generic name","value":"orphenadrine (citrate; oral muscle-relaxant formulation)"},{"label":"ATC code","value":"M03BC01"}]}],"record":[{"label":"Record type","value":"Published interaction record"},{"label":"Source record version","value":"Australian Norflex oral modified-release tablets PI 06.11.2025; government Medicine Finder"}],"sources":[{"label":"Official prescribing information \/ product-characteristics source","url":"https:\/\/www.safetyandquality.gov.au\/medicine-finder\/norflex-tablets"},{"label":"Official prescribing information \/ product-characteristics source","url":"https:\/\/dailymed.nlm.nih.gov\/dailymed\/fda\/fdaDrugXsl.cfm?setid=098c7654-a352-47ee-bf23-6a81f8601266&type=display"}],"reviewed_at":"2026-11-04"},"ism_access":{"required":true,"resource_key":"pair:14185","available":true}}